0001209191-19-015011.txt : 20190301 0001209191-19-015011.hdr.sgml : 20190301 20190301163849 ACCESSION NUMBER: 0001209191-19-015011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190227 FILED AS OF DATE: 20190301 DATE AS OF CHANGE: 20190301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mukhopadhyay Bibhash CENTRAL INDEX KEY: 0001754876 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38697 FILM NUMBER: 19650031 MAIL ADDRESS: STREET 1: 5425 WISCONSIN AVENUE STREET 2: SUITE 800 CITY: CHEVY CHASE STATE: MD ZIP: 20815 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (610) 981-6500 MAIL ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-27 0 0001169245 PhaseBio Pharmaceuticals Inc PHAS 0001754876 Mukhopadhyay Bibhash 5425 WISCONSIN AVENUE SUITE 800 CHEVY CHASE MD 2015 1 0 0 0 Non-employee Director Stock Option (right to buy) 3.15 2019-02-27 4 A 0 36000 0.00 A 2029-02-27 Common Stock 36000 36000 D The Shares subject to the option shall vest in equal monthly installments over 36 months from October 17, 2018, subject to the reporting person's continued service through each such date. /s/ Sasha Keough, attorney-in-fact 2019-03-01